WAS
IPXL

Winch Advisory Services’s Impax Laboratories, Inc. IPXL Stock Holding History

Winch Advisory Services’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-6,786
Closed -$179K – 306
2014
Q1 		$179K Buy
+6,786
New +$170K 0.11% 83

Other funds holding IPXL

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Winch Advisory Services's IPXL Position: Q2 2014 in Review

Winch Advisory Services sold out of Impax Laboratories, Inc. (IPXL) in Q2 2014, closing a stake of 6,786 shares — an estimated $179K sold.

Winch Advisory Services first reported a position in IPXL in Q1 2014 and held it in 1 quarter. The position peaked at $179K in Q1 2014. 185 funds tracked by Wall St. Rank hold IPXL as of Q2 2014.

  • Winch Advisory Services reported no remaining Impax Laboratories, Inc. position as of Q2 2014 after selling out during the quarter.
  • Winch Advisory Services sold 6,786 Impax Laboratories, Inc. shares in Q2 2014, an estimated $179K.
  • Winch Advisory Services first reported a position in Impax Laboratories, Inc. in Q1 2014 and held it in 1 quarter.
  • Winch Advisory Services's Impax Laboratories, Inc. position peaked at $179K in Q1 2014.
  • 185 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2014.

Based on Winch Advisory Services's 13F filing for Q2 2014, filed 15 Aug 2014.